Robinson Value Management, Ltd. Biogen Inc. Transaction History

Robinson Value Management, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$259.0 - $414.71 $1.83 Million - $2.94 Million	-7,079 Reduced 89.93%	793 $275,000
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $99,609 - $116,698	-410 Reduced 4.95%	7,872 $2.2 Million
Q4 2020 Feb 19, 2021	BUY	$236.26 - $355.63 $64,735 - $97,442	274 Added 3.42%	8,282 $2.03 Million
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $90,884 - $125,580	-413 Reduced 4.9%	8,008 $2.38 Million
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $1.85 Million - $2.04 Million	8,421 New	8,421 $1.97 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Robinson Value Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Robinson Value Management, Ltd. with notifications on news.